Literature DB >> 6697993

Enzyme-linked immunosorbent assay for the neuropeptide 'head activator'.

H C Schaller, H Bodenmüller, B Zachmann, E Schilling.   

Abstract

By exposing different sites of the 'head activator', different sets of antibodies were designed and produced which recognised either the amino or the carboxy terminus of the free 'head activator', which reacted with 'head activator' in a tissue-fixed conformation, or which bound to the 'head-activator' sequence, if it was part of a larger precursor-like molecule. An enzyme-linked immunosorbent assay (ELISA) was developed to characterise the antibodies and also to assay minute amounts of 'head activator' or 'head-activator'-like immunoreactivities in animal or tissue extracts. A competitive ELISA is described which uses biotin-avidin for enhancement. The assay is sensitive with an antibody specific for the amino terminus in the range of 0.5-50 fmol, with an antibody specific for the carboxy terminus in the range of 20-400 fmol. The ELISA specific for the amino terminus is 10-times more sensitive than a radio-immunoassay with tritiated 'head activator' [H. Bodenmüller and B. Zachmann (1983) FEBS Lett. 159,237-240]. Previously no radioimmunoassay existed with specificity for the carboxy terminus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697993     DOI: 10.1111/j.1432-1033.1984.tb07924.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.

Authors:  H C Schaller; E Schilling; L Theilmann; H Bodenmüller; W Sachsenheimer
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

2.  Head activator acts as an autocrine growth factor for NH15-CA2 cells in the G2/mitosis transition.

Authors:  H C Schaller; S Druffel-Augustin; S Dübel
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

3.  The neuropeptide head activator loses its biological acitivity by dimerization.

Authors:  H Bodenmüller; E Schilling; B Zachmann; H C Schaller
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

4.  The head activator is released from regenerating Hydra bound to a carrier molecule.

Authors:  H C Schaller; M Roberge; B Zachmann; S Hoffmeister; E Schilling; H Bodenmüller
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.